D'ANGELO, DAVIDE
D'ANGELO, DAVIDE
Dipartimento di Scienze degli Alimenti e del Farmaco
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
2023-01-01 D'Angelo, Davide; Quarta, Eride; Glieca, Stefania; Varacca, Giada; Flammini, Lisa; Bertoni, Simona; Brandolini, Martina; Sambri, Vittorio; Grumiro, Laura; Gatti, Giulia; Dirani, Giorgio; Taddei, Francesca; Bianchera, Annalisa; Sonvico, Fabio; Bettini, Ruggero; Buttini, Francesca
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays
2024-01-01 Patterlini, V.; Guareschi, F.; D'Angelo, D.; Baldini, S.; Meto, S.; Mostafa Kamal, D.; Fabrizzi, P.; Buttini, F.; Mösges, R.; Sonvico, F.
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2
2024-01-01 Guareschi, Fabiola; Del Favero, Elena; Ricci, Caterina; Cantù, Laura; Brandolini, Martina; Sambri, Vittorio; Nicoli, Sara; Pescina, Silvia; D'Angelo, Davide; Rossi, Irene; Buttini, Francesca; Bettini, Ruggero; Sonvico, Fabio
Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device
2023-01-01 D'Angelo, D.; Kooij, S.; Verhoeven, F.; Sonvico, F.; van Rijn, C.
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023)
2023-01-01 D'Angelo, D; Chierici, V; Quarta, E; Varacca, G; Cavalieri, L; Piraino, A; Melani, As; Sonvico, F; Buttini, F
Respicell(TM): An innovative dissolution apparatus for inhaled products
2021-01-01 Sonvico, F.; Chierici, V.; Varacca, G.; Quarta, E.; D'Angelo, D.; Forbes, B.; Buttini, F.
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler
2023-01-01 Varacca, Giada; D'Angelo, Davide; Glieca, Stefania; Cavalieri, Luca; Piraino, Alessio; Quarta, Eride; Sonvico, Fabio; Buttini, Francesca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro | 1-gen-2023 | D'Angelo, Davide; Quarta, Eride; Glieca, Stefania; Varacca, Giada; Flammini, Lisa; Bertoni, Simona; Brandolini, Martina; Sambri, Vittorio; Grumiro, Laura; Gatti, Giulia; Dirani, Giorgio; Taddei, Francesca; Bianchera, Annalisa; Sonvico, Fabio; Bettini, Ruggero; Buttini, Francesca | |
| Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays | 1-gen-2024 | Patterlini, V.; Guareschi, F.; D'Angelo, D.; Baldini, S.; Meto, S.; Mostafa Kamal, D.; Fabrizzi, P.; Buttini, F.; Mösges, R.; Sonvico, F. | |
| Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 | 1-gen-2024 | Guareschi, Fabiola; Del Favero, Elena; Ricci, Caterina; Cantù, Laura; Brandolini, Martina; Sambri, Vittorio; Nicoli, Sara; Pescina, Silvia; D'Angelo, Davide; Rossi, Irene; Buttini, Francesca; Bettini, Ruggero; Sonvico, Fabio | |
| Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device | 1-gen-2023 | D'Angelo, D.; Kooij, S.; Verhoeven, F.; Sonvico, F.; van Rijn, C. | |
| No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) | 1-gen-2023 | D'Angelo, D; Chierici, V; Quarta, E; Varacca, G; Cavalieri, L; Piraino, A; Melani, As; Sonvico, F; Buttini, F | |
| Respicell(TM): An innovative dissolution apparatus for inhaled products | 1-gen-2021 | Sonvico, F.; Chierici, V.; Varacca, G.; Quarta, E.; D'Angelo, D.; Forbes, B.; Buttini, F. | |
| The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler | 1-gen-2023 | Varacca, Giada; D'Angelo, Davide; Glieca, Stefania; Cavalieri, Luca; Piraino, Alessio; Quarta, Eride; Sonvico, Fabio; Buttini, Francesca |